[Advances of IL-33/ST2 Signaling Pathway in Allergic Rhinitis]

Overview

Journal Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi

Specialty Otorhinolaryngology

Date 2020 Aug 26

PMID 32842193

Citations 3

Authors

Guo Liu

Feng Liu

Affiliations

Soon will be listed here.

Abstract

Interleukin-33 that binds to the membrane receptor ST2L, can not only regulate mast cells, eosinophils, and group 2 innate lymphoid cells（ILC2s）, but also affect the function of regulatory T cells（Treg） and Follicular helper T cells（Tfh）. Interleukin-33 can activate the NF-κB and MAPK signaling pathways of the above cells, then participates in allergic immunity reaction. IL-33/ST2 signaling pathway is closely related to the allergic rhinitis（AR）. IL-33 has been used as a new biomarker to evaluate the effect of AR treatment. At the same time, antagonizing IL-33 is also expected to become a new treatment. This article reviewed the latest research of IL-33/ST2 signaling pathway in the field of AR.

Citing Articles

Exploring the Core Prescription and Underlying Mechanism of Traditional Chinese Medicine in Treating Allergic Rhinitis in Children: A Real- World Study Based on an Illustrious Senior Traditional Chinese Medicine Practitioner.

Luo C, Wang Y, He B, He Y, Yan Y, Wang J Comb Chem High Throughput Screen. 2022; 26(1):207-223.

PMID: 35388748 DOI: 10.2174/1386207325666220406105633.

Jin-Wu-Jian-Gu Formulation Attenuates Rheumatoid Arthritis by Inhibiting the IL33-ST2 Signaling Pathway.

Lu D, Huang Y, Ma W, Chen C, Hou L Evid Based Complement Alternat Med. 2022; 2022:6821388.

PMID: 35096114 PMC: 8794654. DOI: 10.1155/2022/6821388.

Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients.

Zhu K, Xia C, Chen J, Yu C, Gao T, Yan J Mediators Inflamm. 2021; 2021:5576596.

PMID: 34194284 PMC: 8181096. DOI: 10.1155/2021/5576596.

References

Nagashima H, Okuyama Y, Fujita T, Takeda T, Motomura Y, Moro K . GITR cosignal in ILC2s controls allergic lung inflammation. J Allergy Clin Immunol. 2018; 141(5):1939-1943.e8. DOI: 10.1016/j.jaci.2018.01.028. View

Fan H, Qin T, Ye L, Li F, Lin G, Liang Y . [Expression of IL-25 and IL-33 and the count of EOS in peripheral blood of children with allergic rhinitis receiving immunotherapy]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018; 32(6):443-446. DOI: 10.13201/j.issn.1001-1781.2018.06.011. View

Iinuma T, Okamoto Y, Morimoto Y, Arai T, Sakurai T, Yonekura S . Pathogenicity of memory Th2 cells is linked to stage of allergic rhinitis. Allergy. 2017; 73(2):479-489. DOI: 10.1111/all.13295. View

Vasanthakumar A, Moro K, Xin A, Liao Y, Gloury R, Kawamoto S . The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat Immunol. 2015; 16(3):276-85. DOI: 10.1038/ni.3085. View

Kim J, Yoon M, Seo D, Kim B, Ban G, Ye Y . Detection of Allergen Specific Antibodies From Nasal Secretion of Allergic Rhinitis Patients. Allergy Asthma Immunol Res. 2016; 8(4):329-37. PMC: 4853510. DOI: 10.4168/aair.2016.8.4.329. View

Bird L . Regulatory T cells: Ageing muscles lose T Reg-eneration. Nat Rev Immunol. 2016; 16(4):204. DOI: 10.1038/nri.2016.30. View

Chen C, Kobayashi T, Iijima K, Hsu F, Kita H . IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs. J Allergy Clin Immunol. 2017; 140(5):1351-1363.e7. PMC: 5554091. DOI: 10.1016/j.jaci.2017.01.015. View

Stier M, Zhang J, Goleniewska K, Cephus J, Rusznak M, Wu L . IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow. J Exp Med. 2017; 215(1):263-281. PMC: 5748848. DOI: 10.1084/jem.20170449. View

Baumann C, Bonilla W, Frohlich A, Helmstetter C, Peine M, Hegazy A . T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses. Proc Natl Acad Sci U S A. 2015; 112(13):4056-61. PMC: 4386370. DOI: 10.1073/pnas.1418549112. View

10.

Arpaia N, Green J, Moltedo B, Arvey A, Hemmers S, Yuan S . A Distinct Function of Regulatory T Cells in Tissue Protection. Cell. 2015; 162(5):1078-89. PMC: 4603556. DOI: 10.1016/j.cell.2015.08.021. View

11.

Gluck J, Rymarczyk B, Rogala B . Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity. Inflamm Res. 2012; 61(6):547-50. PMC: 3345109. DOI: 10.1007/s00011-012-0443-9. View

12.

Kim Y, Yang T, Park C, Ahn S, Son B, Kim J . Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy. 2011; 67(2):183-90. DOI: 10.1111/j.1398-9995.2011.02735.x. View

13.

Haenuki Y, Matsushita K, Futatsugi-Yumikura S, Ishii K, Kawagoe T, Imoto Y . A critical role of IL-33 in experimental allergic rhinitis. J Allergy Clin Immunol. 2012; 130(1):184-94.e11. DOI: 10.1016/j.jaci.2012.02.013. View

14.

Bonilla W, Frohlich A, Senn K, Kallert S, Fernandez M, Johnson S . The alarmin interleukin-33 drives protective antiviral CD8⁺ T cell responses. Science. 2012; 335(6071):984-9. DOI: 10.1126/science.1215418. View

15.

Leaker B, Malkov V, Mogg R, Ruddy M, Nicholson G, Tan A . The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement. Mucosal Immunol. 2016; 10(2):408-420. DOI: 10.1038/mi.2016.74. View

16.

Liew F, Girard J, Turnquist H . Interleukin-33 in health and disease. Nat Rev Immunol. 2016; 16(11):676-689. DOI: 10.1038/nri.2016.95. View

17.

Drake L, Kita H . IL-33: biological properties, functions, and roles in airway disease. Immunol Rev. 2017; 278(1):173-184. PMC: 5492954. DOI: 10.1111/imr.12552. View

18.

Cavagnero K, Doherty T . Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease. J Cytokine Biol. 2017; 2(2). PMC: 5614509. DOI: 10.4172/2576-3881.1000116. View

19.

Wang Y, Li C, Xu Y, Xu D, Yang G, Liao F . Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis. Indian J Pediatr. 2018; 85(10):872-876. DOI: 10.1007/s12098-018-2703-3. View

20.

Zhao P, Shi X, Li C, Ayana D, Niu J, Feng J . IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells. J Interferon Cytokine Res. 2015; 35(6):454-63. PMC: 4490772. DOI: 10.1089/jir.2013.0122. View